We've found
9,144
archived clinical trials in
Ocular
We've found
9,144
archived clinical trials in
Ocular
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
Updated: 12/31/1969
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration
Updated: 12/31/1969
A Randomized, Double-Masked, Vehicle-Controlled Proof-Of-Concept Study for Topically Delivered LHA510 as a Maintenance Therapy in Patients With Wet Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration
Updated: 12/31/1969
A Randomized, Double-Masked, Vehicle-Controlled Proof-Of-Concept Study for Topically Delivered LHA510 as a Maintenance Therapy in Patients With Wet Age-Related Macular Degeneration (AMD)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
Updated: 12/31/1969
A Multi-Center, Three-Stage, Open-Label, Prospective, Active-Comparator-Controlled Phase 2a Study of ENV515 (Travoprost) Intracameral Implant in Patients With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Updated: 12/31/1969
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials